Xagena Medical News – 3

Lantus associated with an increased risk for breast cancer     Adults with type 2 diabetes: Saxagliptin when added to Insulin maintains reductions in glycosylated hemoglobin levels over 52 weeks     No link between intracerebral hemorrhage and statin use among patients with prior stroke     Transthyretin familial amyloid polyneuropathy: Vyndaqel, first therapy approved in the European Union   … Continua a leggere

Xagena Medical News – 2

Increased mortality risk associated with drugs for insomnia or anxiety   Patients with acute coronary syndrome and on Fondaparinux: safety of two intravenous Heparin doses as adjunct to PCI   Switch to metronomic chemotherapy could offer new treatment option in metastatic renal-cell cancer   Lung adenocarcinoma progressed after treatment with EGFR inhibitors: Afatinib improves progression-free   Patients with paroxysmal atrial … Continua a leggere

Xagena Medical News – 1

Insulin glargine, possible cancer link   Raxibacumab for treatment of inhalation anthrax disease   Hypercholesterolemia: Pitavastatin is non-inferior to Atorvastatin and Simvastatin   Potential risk of meningiomas with high-dose Cyproterone acetate   Breast cancer: oligohydramnios associated with Herceptin   Risk of histoplasmosis and other invasive fungal infections associated with Enbrel   ODAC recommends against approving Tarceva for first-line maintenance use … Continua a leggere